PRME · Prime Medicine, Inc. · Webcasts, Transcripts & Audio
$3.82
-0.10 (-2.55%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$711.00M
Shares
181.38M
Volume · Oct 21
2.43M
Avg daily vol (3M)
3.49M
Prime Medicine, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Prime Medicine, Inc. (PRME), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-16
Prime Medicine, Inc. (PRME) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Prime Medicine, Inc. (PRME) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-10
Prime Medicine, Inc. (PRME) June 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Prime Medicine, Inc. (PRME) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-12
Prime Medicine, Inc. (PRME) Q3 2025 Earnings Call
Revenue
$1.23M
▲ 486.1% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 webcasts
Key facts
CIK
1894562
CUSIP
74168J101
13F (30d)
14 filings
14 filers
Visit website
Investor relations